Adverse Events : Race, Inequality, and the Testing of New Pharmaceuticals /

Mostrar otras versiones (2)

Explores the social inequality of clinical drug testing and its effects on scientific resultsImagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to.

Detalles Bibliográficos
Autor principal: Fisher, Jill A. (Autor, Verfasser.)
Formato: Electrónico
Idioma:Inglés
Publicado: New York, NY New York University Press [2020]
Colección:Book collections on Project MUSE.
Temas:
SOCIAL SCIENCE / Anthropology / General.
validity.
study compensation.
social world.
social network.
social inequality.
social inequalities.
serial participation.
screen failure.
risk.
research staff.
research participation.
reputation.
region.
race.
qualifying.
public health.
profit.
phase I.
phase I trials.
phase I industry.
phase I clinical trials.
pharmaceutical industry.
participation.
opportunism.
model organism.
methods.
informed consent.
inclusion-exclusion criteria.
clinic;clinical trial culture;clinical trials;clinics;confinement;consumption;decision making;demographics;drug development;economic interests;economic motivations;economic need;economic risk;epistemology;health-promoting behavior;healthy volunteers;identity;imbricated stigma.
United States.
Electronic books.
Acceso en línea:Texto completo
Search Result 1
Adverse Events : Race, Inequality, and the Testing of New Pharmaceuticals /
por Fisher, Jill A.
Publicado 2020
Texto completo
Texto completo
Electrónico eBook
Search Result 2
Adverse events : race, inequality, and the testing of new pharmaceuticals /
por Fisher, Jill A., 1976-
Publicado 2020
Texto completo
Electrónico eBook
Mostrar todas las versiones(3)

Ejemplares similares